17 April 2026.
Undersea Defence Technology 2026 has closed in London, and its implications are only just becoming clear.
Across three days, a clear pattern emerged: undersea defence is moving from concept to deployable capability. Autonomy, integration and infrastructure protection are shaping both investment and procurement priorities.
Within that broader context, AUKUS emerged as a key signal of how these trends are translating into long-term programmes.
UDT 2026 provided a clear platform for industry and government to reaffirm progress on AUKUS, with several concrete updates shared.
Building on its March 2026 update, Rolls-Royce provided further insight at UDT, with James Lowe, Director of Future Programmes at Rolls-Royce Submarines, confirming that key milestones in propulsion unit development have been passed.
Seven reactors are currently under construction in Derby, with manufacturing pace doubling as demand increases. Progress on the PWR3+ reactor and next steps in the programme were also discussed, with multiple speakers reinforcing that AUKUS remains on track and progressing to schedule.
The March 2026 update noted:
“During the year, Rolls-Royce Submarines alongside Assystem, AtkinsRéalis and Frazer-Nash formed the Capability Assured Strategic Partnership, bringing together nuclear capability in the UK to support the Royal Navy’s submarine programme and the wider Defence Nuclear Enterprise.”
The company also confirmed agreements with Australian partners, including the State of Victoria, focused on developing defence industry skills, supply chains and innovation ecosystems, building on earlier agreements with Western and South Australia.
These developments reflect the growing industrial base underpinning AUKUS, as well as the increasing pace of delivery across the programme.
They also follow the UK Government’s 8 April update to the Open General Licence covering AUKUS nations, providing further regulatory support for collaboration across the UK, US and Australia.
None of this implies smooth sailing. Industry sources at UDT quietly highlighted workforce constraints in UK and Australian nuclear supply chains as the next critical path.
AUKUS is moving beyond strategic alignment into industrial execution.
Progress on reactor development, supply chain integration and regulatory alignment indicates that the programme is entering a more delivery-focused phase. The emphasis is shifting from commitment to capability.
This matters well beyond submarine platforms. AUKUS is shaping long-term demand across nuclear engineering, advanced manufacturing, autonomy and undersea systems, while reinforcing the importance of industrial capacity and supply chain depth.
For suppliers, this creates opportunity across multiple tiers of the value chain. For governments, it raises the challenge of sustaining delivery at pace over long programme timelines.
UDT 2026 has reinforced a consistent message across the undersea domain: capability is no longer defined by what can be designed, but by what can be delivered, integrated and sustained.
AUKUS now sits at the centre of that shift.
Alongside AUKUS, discussions at UDT 2026 also highlighted parallel European priorities, including infrastructure protection, mine warfare and regional capability development, reinforcing that the undersea domain is evolving across multiple strategic tracks.
Follow Visiongain for further AUKUS analysis, including supply chain positioning, industrial capacity and long-term market impact.
Visiongain’s undersea and maritime intelligence hub brings together the latest briefings, analysis and market insights shaping this rapidly evolving domain.
From autonomy and subsea infrastructure protection to naval platforms and system integration, the hub provides a central resource for understanding how demand, investment and capability are developing across global undersea markets.
Explore Visiongain’s undersea and maritime intelligence, and access related market reports: https://visiongain.com/market-watch-undersea/
For commentary, data requests or interview enquiries, please contact: press@visiongain.com
See where vaccine growth is shifting before strategy, investment and partnership decisions are made.
As growth moves beyond traditional vaccine volumes, companies that understand where demand, platforms and capacity are converging will be better placed to make faster strategy, investment and partnership decisions.
Download the free report to understand:
➤ Where vaccine demand is broadening beyond traditional immunisation
➤ How mRNA is moving from emergency-response technology to repeatable platform strategy
➤ How fill-finish, CDMO access and regional manufacturing could shape execution
➤ Which companies are positioned across vaccines, mRNA, oncology and manufacturing
"*" indicates required fields
"*" indicates required fields
Your shopping cart is empty
Notifications